An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo
- PMID: 1680225
- DOI: 10.1016/0306-4522(91)90383-y
An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo
Abstract
Injection of the N-methyl-D-aspartate receptor agonist quinolinate, or N-methyl-D-aspartate itself, into the rat brain produces neurodegeneration which can be prevented by N-methyl-D-aspartate receptor antagonists administered up to 5 h after excitotoxin injection. The present study was designed to investigate aspects of the mechanisms involved in this delayed form of neurodegeneration. Following its injection into the rat striatum, extracellular levels of [3H]quinolinate were monitored using a microdialysis probe located 1 mm from the site of injection. Peak concentrations were observed 10-20 min after injection and [3H]quinolinate levels decayed in a biexponential fashion, the initial component having an apparent t1/2 of 13.7 +/- 5.2 min (n = 3). Estimations of the extracellular concentrations of quinolinate after an injection of 200 nmol indicated a peak level of 13.7 +/- 6.0 mM (n = 3) at 10-20 min which declined to 1.2 +/- 0.13 mM (n = 3) by 2 h and substantial levels were present up to 5 h, the period over which N-methyl-D-aspartate receptor antagonists are effective in this model. Administration of dizocilpine at 1, 2, 3 or 5 h after injection of 100, 200 or 400 nmol quinolinate resulted in a similar temporal profile of neuroprotection, as assessed by measuring the activities of choline acetyltransferase and glutamate decarboxylase in striatal homogenates, which was independent of the degree of neurodegeneration produced by the different excitotoxin doses. Overall, these results suggest that the neuronal degeneration caused by quinolinate in vivo is critically dependent upon events occurring after the initial peak of excitoxin levels in the extracellular space.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.J Neurosci. 1988 Dec;8(12):4745-54. doi: 10.1523/JNEUROSCI.08-12-04745.1988. J Neurosci. 1988. PMID: 2904493 Free PMC article.
-
A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.Neuroscience. 1993 Aug;55(4):883-92. doi: 10.1016/0306-4522(93)90305-y. Neuroscience. 1993. PMID: 7694181
-
Plasma and CSF levels of dizocilpine (MK-801) required for neuroprotection in the quinolinate-injected rat striatum.Eur J Pharmacol. 1991 Apr 24;196(3):285-90. doi: 10.1016/0014-2999(91)90441-r. Eur J Pharmacol. 1991. PMID: 1832637
-
An evaluation of the role of extracellular amino acids in the delayed neurodegeneration induced by quinolinic acid in the rat striatum.Neuroscience. 1993 Feb;52(4):911-7. doi: 10.1016/0306-4522(93)90537-p. Neuroscience. 1993. PMID: 8095713
-
Endogenous excitotoxic agents.Ciba Found Symp. 1987;126:204-20. doi: 10.1002/9780470513422.ch13. Ciba Found Symp. 1987. PMID: 2884085 Review.
Cited by
-
Vicious cycle involving Na+ channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation.J Neurosci. 1996 Aug 15;16(16):5004-13. doi: 10.1523/JNEUROSCI.16-16-05004.1996. J Neurosci. 1996. PMID: 8756431 Free PMC article.
-
Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.Br J Pharmacol. 2002 Jan;135(1):103-12. doi: 10.1038/sj.bjp.0704449. Br J Pharmacol. 2002. PMID: 11786485 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources